- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05868343
Effectiveness of a Hybrid Cardiac Rehabilitation Program
Pragmatic Randomized Controlled Trial to Promote Physical Activity Through Home Exercise After Cardiac Rehabilitation
The goal of this pragmatic randomized clinical trial is to compare the effectiveness of a hybrid model of cardiac rehabilitation with a centre-based program in people with cardiovascular disease. The main question it aims to answer is:
• How effective is a hybrid model of CR for people with cardiovascular disease living in a francophone minority community compared to a centre-based model of CR in terms of leading to maintenance of gains (physical activity level, functional capacity, mental health, quality of life) six months after CR? Participants will undergo a 12-week hybrid cardiac rehabilitation program. For the first six weeks, patients will be required to attend the hospital twice a week. After that, there will be a gradual increase in home sessions for the remaining six weeks. When a patient has a home session, health professionals will follow up with a weekly phone call.
Researchers will compare the centre-based cardiac rehabilitation program with the hybrid program to see if the hybrid program can better maintain the level of physical activity, mental health, functional capacity, and quality of life six months after the end of the program.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Brunswick
-
Bathurst, New Brunswick, Canada
- Hôpital régional Chaleur
-
Bouctouche, New Brunswick, Canada
- Centre J.K. Irving
-
Campbellton, New Brunswick, Canada
- Hôpital Régional de Campbellton
-
Caraquet, New Brunswick, Canada
- Hôpital de l'Enfant-Jésus RHSJ
-
Edmundston, New Brunswick, Canada
- Hôpital régional d'Edmundston
-
Grand Falls, New Brunswick, Canada
- Hôpital général de Grand-Sault
-
Moncton, New Brunswick, Canada
- Coeur en santé
-
Saint-Quentin, New Brunswick, Canada
- Hôtel-Dieu Saint-Joseph de Saint-Quentin
-
Tracadie, New Brunswick, Canada
- Hôpital de Tracadie
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Be and adult (over 19 years old)
- Be eligible for Vitalité Health Network Cardiac rehabilitation program.
Exclusion Criteria:
- Have a physical or cognitive condition that precludes participation in an exercise program.
- Have previously participated in a CR program.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Center-based cardiac rehabilitation program
|
The center-based cardiac rehabilitation program is 12 weeks in length.
Participants will travel to the center twice a week for the duration of the program.
Participants receive an individualized exercise program to be completed at the center according to Canadian recommendations.
Twelve pre-recorded educational vignettes on various health topics and two group educational sessions on nutrition are offered to participants in person during the first twelve sessions at the center.
In addition, at the beginning of the CR program, participants watch a motivational vignette from one of our patient partners about the importance and benefits of following the CR program.
Depending on the needs of each participant, they may be referred to various external clinics within the Vitalité network, such as the Nutrition Service.
|
|
Experimental: Hybrid cardiac rehabilitation program
|
The center-based cardiac rehabilitation program is 12 weeks in length.
For the first six weeks, participants are required to attend the hospital twice a week.
After that, there will be a gradual increase in home sessions for the remaining six weeks.
When a patient has a home session, health professionals follow up with a phone call.Twelve pre-recorded educational vignettes on various health topics and two group educational sessions on nutrition are offered to participants in person during the first twelve sessions at the center.
In addition, at the beginning of the CR program, participants watch a motivational vignette from one of our patient partners about the importance and benefits of following the CR program.
Depending on the needs of each participant, they may be referred to various external clinics within the Vitalité network, such as the Nutrition Service.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in level of Physical Activity
Time Frame: Questionnaire will be completed at 0 months, 3 months and 9 months
|
Description: The Level of Physical Activity will be collected using the International Physical Activity Questionnaire (IPAQ).
|
Questionnaire will be completed at 0 months, 3 months and 9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in health-Related Quality of Life
Time Frame: Questionnaire will be completed at 0 months, 3 months and 9 months
|
The Health-Related Quality of life will be collected using the Euro-QoL 5-dimension Questionnaire (EQ-5D-5L).
The EQ-5D-5L can be summarized as an index value varying from -0.148 (worst score) to +0.949 (best score).
|
Questionnaire will be completed at 0 months, 3 months and 9 months
|
|
Change in functional Capacity
Time Frame: Questionnaire will be completed at 0 months, 3 months and 9 months
|
The Functional Capacity will be evaluated using the six-minute walk test (6MWT).
|
Questionnaire will be completed at 0 months, 3 months and 9 months
|
|
Change in anxiety and Depression
Time Frame: Questionnaire will be completed at 0 months, 3 months and 9 months
|
Anxiety and depression will be collected using the Hospital Anxiety and Depression Scale (HADS).
The total score ranges from 0 to 21 for each subscale (anxiety and depression).
A higher score indicates a greater risk of having an anxiety or depression disorder.
|
Questionnaire will be completed at 0 months, 3 months and 9 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Pamela Tanguay, Universite de Sherbrooke
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 101745
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Center-based Cardiac Rehabilitation Intervention
-
Mayo ClinicJohns Hopkins University; University of California, Irvine; University of Mississippi...CompletedCardiovascular Diseases | Telemedicine | Cardiac EventUnited States
-
Riphah International UniversityCompletedCoronary Heart DiseasePakistan
-
Hanoi Medical UniversityNot yet recruitingValvular DiseasesVietnam
-
KU LeuvenHasselt University; Jessa HospitalCompletedMyocardial Infarction | Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | Percutaneous Transluminal Cutting Balloon Angioplasty of Popliteal Vein Using Fluoroscopic GuidanceBelgium
-
The University of Hong KongRecruitingCoronary Artery DiseaseHong Kong
-
Azienda Ospedaliero Universitaria di SassariCompletedHeart Failure | Cardiac RehabilitationItaly
-
ADIR AssociationEuropean Union; Hopital La Musse; Groupe Hospitalier du Havre; Centre Hospitalier... and other collaboratorsRecruitingChronic Obstructive Pulmonary Disease (COPD)France
-
Federico II UniversityCompletedAcute Myocardial InfarctionItaly
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteCompleted
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedCardiovascular Diseases | Cardiac Risk FactorsBrazil